Clinical trial
Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic…
NCT00104689 · UNICANCER, Other · Completed
Key facts
| NCT number | NCT00104689 |
|---|---|
| Title | Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer |
| Official title | Phase II Trial Assessing the Impact on the Activity of Daily Living of an Oral Chemotherapy by Capecitabine Associated With an Intravenous Chemotherapy by Oxaliplatin as First Line Treatment of Metastatic Colorectal Adenocarcinoma of Patients Aged Over 70 |
| Lead sponsor | UNICANCER, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | capecitabine, oxaliplatin |
| Enrollment | 60 |
| Start date | Jun 30, 2003 |
| Primary completion | Mar 31, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Mar 4, 2005 |
| Last update posted | Feb 21, 2021 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: